<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166383">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01762098</url>
  </required_header>
  <id_info>
    <org_study_id>OVO-12-20</org_study_id>
    <nct_id>NCT01762098</nct_id>
  </id_info>
  <brief_title>Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization</brief_title>
  <official_title>Prevalence of Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OVO R &amp; D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>OVO R &amp; D</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic endometritis is a persistent inflammation of the endometrium. Chronic endometritis
      is asymptomatic or little symptomatic. Sometimes, patient with chronic endometritis can have
      genital bleeding, pelvic chronic pain, pain during sexual relations, persistent vaginal
      white loosing. The hysteroscopy can detect the presence or absence of chronic endometritis.

      Some studies showed that the endometritis could have an impact on the embryo implantation
      and could explain recurrent miscarriages or repeated embryo implantation failures.

      The goal of this study is to evaluate the frequency of the chronic endometritis in patients
      with recurrent miscarriages or repeated embryo implantation failures
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Rate of chronic endometritis</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Infertility</condition>
  <condition>Endometritis</condition>
  <condition>Abortion, Spontaneous</condition>
  <arm_group>
    <arm_group_label>Recurrent miscarriages</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Repeated embryo implantation failures</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Population with recurrent miscarriage or repeated embryo implantation failures.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Group repeated miscarriages

          -  Women aged 18 to 43 years

          -  ≥ 2 miscarriages before 14 weeks of gestation

          -  Genetic (karyotype x2), thrombophilic and endocrine assessment should be completed

        Group of implantation failure in In-vitro fertilization

          -  Women aged 18 to 45 years

          -  Absence of pregnancy after 3 good quality embryos transferred in women under  35
             years and 4 embryos in the 35 years and over.

        Exclusion Criteria:

          -  Positive pregnancy test

          -  Unexplained bleeding

          -  Incomplete miscarriage assessment

          -  Uterine malformation

          -  Antibiotic treatment during or within one month prior to the biopsy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Élise Monceau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Montréal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique Ovo</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H4P 2S4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 12, 2014</lastchanged_date>
  <firstreceived_date>January 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>In vitro fertilization</keyword>
  <keyword>Hysteroscopy</keyword>
  <keyword>Endometrial biopsy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Abortion, Habitual</mesh_term>
    <mesh_term>Endometritis</mesh_term>
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
